Breast cancer surgery has two main options: removing the tumour while preserving the breast, followed by radiotherapy, or removing the whole breast (mastectomy). In long-term trials, survival was similar between the two for suitable patients, so the choice depends on tumour size, position and features, and on the patient’s preference [3][4][9].
Signs that need a check-up
- A new lump in the breast or armpit.
- Swelling of part of the breast, skin dimpling, or redness or thickening of the skin or nipple.
- A nipple turning inward, nipple discharge other than milk, or breast or nipple pain [8].
Most breast lumps are not cancer, but any new change should be checked by a doctor [8].
How is it diagnosed?
Diagnosis uses mammography and ultrasound, MRI in specific situations, and then a biopsy to confirm it [1]. The sample is tested for hormone receptors (ER and PR) and HER2, which help predict response to hormone and targeted therapy [1]. Treatment decisions are made after multidisciplinary team assessment and together with the patient [2].
Breast-conserving surgery or mastectomy?
In the NSABP B-06 trial there was no significant difference in survival over 20 years between mastectomy and lumpectomy (with or without radiotherapy) [3]. In the Milan trial of small tumours, survival was similar after breast conservation with radiotherapy and radical mastectomy, with more recurrence in the same breast after conservation [4].
Radiotherapy after breast conservation clearly reduces the risk of recurrence, and the size of the benefit varies with patient and tumour features [5], so most patients need radiotherapy after lumpectomy [9]. Omitting it may be discussed in a very specific low-risk group [2].
What determines the choice? Tumour size relative to breast size, more than one tumour area, previous breast radiotherapy, and pregnancy or some connective-tissue diseases [9]. If cancer cells are found at the edges of the removed tissue, a second operation may be needed [9]. In some cases chemotherapy or hormone therapy is given before surgery to shrink the tumour [2].
Lymph nodes in the armpit
If imaging or needle biopsy shows no involvement of armpit nodes, sentinel lymph node biopsy is used instead of full axillary clearance [2]. In the NSABP B-32 trial, outcomes were similar without full clearance when sentinel nodes were negative [6]. If the sentinel node is involved, treatment may be completed with axillary clearance or radiotherapy; in the AMAROS trial axillary recurrence was low and similar with either, with less arm swelling after radiotherapy [7].
Possible complications
- Bleeding, infection, pain, fluid collection (seroma), change in breast shape or numbness [9].
- Arm lymphoedema: more common after axillary clearance than after sentinel node biopsy; it can appear within the first two years after surgery, and overweight increases the risk [10].
Patients should be told about the risk of lymphoedema before treatment and given arm and shoulder exercises; there is no evidence that exercise makes lymphoedema worse [2].
Breast reconstruction
UK guidance recommends discussing breast reconstruction with every patient who needs a mastectomy, either at the same operation or later, including the uncertainty about long-term results with radiotherapy [2].
Recovery and follow-up
Lumpectomy is often a same-day procedure, and many patients return to usual activities within a few weeks, though this varies [9]. Follow-up usually includes yearly mammograms for several years and a written care plan for each patient [2].
Frequently asked questions
Is removing the whole breast safer than conserving it?
For patients suitable for breast conservation, long-term trials showed similar survival between the two options, with radiotherapy usually needed after conservation [3][4][9].
Will I need full axillary clearance?
Not always. When there is no clear node involvement, sentinel node biopsy is used first [2][6].
Is every breast lump cancer?
No, most lumps are not cancer, but they need a medical check [8].
Read next
Want your symptoms checked? Book a consultation with Dr. John Kamal Ibrahim, consultant colorectal surgeon, at Surgycare Clinic in Gianaclis, Alexandria — Saturday to Wednesday, 5–9 pm. Book an appointment or call +20 120 100 5950.
This article is general health education and does not replace a medical consultation. The right treatment is decided for each patient after a clinical assessment.
Medical references
- Breast Cancer Treatment (PDQ®)–Health Professional Version. National Cancer Institute. 2025. cancer.gov
- Early and locally advanced breast cancer: diagnosis and management (NG101). National Institute for Health and Care Excellence (NICE). 2018, updated 2025. nice.org.uk/guidance/ng101
- Fisher B, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine. 2002;347:1233–1241. doi:10.1056/NEJMoa022152
- Veronesi U, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New England Journal of Medicine. 2002;347:1227–1232. doi:10.1056/NEJMoa020989
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death. The Lancet. 2011;378:1707–1716. doi:10.1016/S0140-6736(11)61629-2
- Krag DN, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer (NSABP B-32). Lancet Oncology. 2010;11:927–933. doi:10.1016/S1470-2045(10)70207-2
- Donker M, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS). Lancet Oncology. 2014;15:1303–1310. doi:10.1016/S1470-2045(14)70460-7
- Breast Cancer Signs and Symptoms. American Cancer Society. 2026. cancer.org
- Breast-conserving Surgery (Lumpectomy). American Cancer Society. cancer.org
- DiSipio T, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncology. 2013;14:500–515. doi:10.1016/S1470-2045(13)70076-7
